SCHEMBL27371606

SCHEMBL27371606

Nc1cc(-n2cnnc2)cc2c1cnn2C1CCCCO1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ RXRA P19793 1/20 0.39
▸ RXRB P28702 1/20 0.39
▸ RXRG P48443 1/20 0.39
▸ CYP4F2 P78329 2/20 0.35
▸ CYP4A11 Q02928 2/20 0.35
▸ KMT2A Q03164 2/20 0.33
▸ ATR Q13535 7/20 0.32
▸ RET P07949 5/20 0.32
▸ GAA P10253 1/20 0.32
▸ TP53 P04637 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ NFKB1 P19838 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ APEX1 P27695 1/20 0.30
▸ PI4KA P42356 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27376543 0.86 RXRA (0.41) ALDH1A1LMNAPOLBRXRARXRB
SCHEMBL27371610 0.85 CYP4F2 (0.38) ALDH1A1LMNAPOLBRXRARXRB
SCHEMBL27371608 0.83 ALDH1A1 (0.40) ALDH1A1LMNAPOLBRXRARXRB
SCHEMBL27377479 0.82 ALDH1A1 (0.38) ALDH1A1LMNAPOLBRXRARXRB
SCHEMBL27371856 0.82 ATR (0.43) ALDH1A1LMNAPOLBATR
SCHEMBL27377578 0.82 ALDH1A1 (0.39) ALDH1A1LMNAPOLBRXRARXRB
SCHEMBL32690886 0.82 ALDH1A1 (0.39) ALDH1A1LMNAPOLBRXRARXRB
SCHEMBL27376556 0.80 ALDH1A1 (0.46) ALDH1A1LMNAPOLBRXRARXRB
SCHEMBL30869155 0.79 RXRA (0.37) ALDH1A1LMNAPOLBRXRARXRB
SCHEMBL27371860 0.78 CYP4F2 (0.40) ALDH1A1LMNAPOLBRXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024052701-A1 NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF CAMBRIDGE ENTERPRISE LIMITED (GB) 2024-03-14 — — WO disclosed
WO-2024052702-A1 NOVEL COMPOUNDS AS CK2 INHIBITORS CAMBRIDGE ENTERPRISE LIMITED (GB) 2024-03-14 — — WO disclosed
Send feedback